Florid mesothelial hyperplasia associated with ovarian tumors: a potential source of error in tumor diagnosis and staging
other
OA: closed
public-domain-us
⚙
AI-generated summary
by qwen3.7-flash, 2026-08-21
ⓘ
Florid mesothelial hyperplasia associated with ovarian tumors, often linked to coexistent endometriosis, can mimic metastatic disease and cause diagnostic errors in tumor classification and staging.
⚙
AI-generated deep summary
by qwen3.7-flash, 2026-08-21
· read from full text
ⓘ
This study examines five cases of ovarian tumors complicated by florid mesothelial hyperplasia, which initially led to misdiagnosis or staging errors. In these instances, atypical mesothelial cell proliferations were mistaken for stromal invasion, lymphatic invasion, or metastatic disease due to their architectural resemblance to malignancy. The authors identify predisposing factors such as large tumor size, ascites, and coexistent endometriosis, emphasizing that recognizing these benign reactive changes is crucial for accurate classification and management. This paper is centrally about endometriosis — specifically noting it as a predisposing factor for florid mesothelial hyperplasia in patients with ovarian neoplasms.
Abstract
Five ovarian tumors were associated with florid mesothelial hyperplasia that in four cases created initial problems in histologic classification and staging of the tumors. In two cases, small nests, cords, and gland-like arrangements of atypical mesothelial cells within the cyst wall of a serous or mullerian mucinous tumor of borderline malignancy were initially considered to possibly represent, or were misdiagnosed as, foci of stromal invasion, lymphatic invasion, or both. In the three other cases--an endometrioid adenocarcinoma, a struma ovarii, and a yolk sac tumor--papillary and sheet-like proliferations of mesothelial cells involved the extraovarian pelvic peritoneum; in one of the cases, necrosis of the mesothelial cells was prominent. These foci of extra-ovarian mesothelial hyperplasia were interpreted as metastatic tumor intraoperatively (three cases) and on initial microscopic examination (two cases). Factors that may have predisposed to the mesothelial hyperplasia included large size of the primary tumor (two cases), the presence of metastatic tumor elsewhere in the pelvis (three cases), ascites (two cases), and coexistent endometriosis (two cases). Distinction of mesothelial proliferation from invasive or metastatic ovarian tumor is obviously important in correct classification, staging, and management of the tumor. Awareness of the occasional occurrence of florid mesothelial hyperplasia in patients with ovarian neoplasms and attention to the histologic, histochemical, and immunohistochemical features of the mesothelial proliferation should facilitate the correct diagnosis.
Full text
1,781 characters
· extracted from
oa-doi-fallback
· click to expand
Florid Mesothelial Hyperplasia Associated with Ovarian Tumors
A Potential Source of Error in Tumor Diagnosis and Staging
- Philip B. Clement
- Robert H. Young
Summary:
Five ovarian tumors were associated with florid mesothelial hyper- plasia that in four cases created initial problems in histologic classification and staging of the tumors. In two cases, small nests, cords, and gland-like arrangements of atypical mesothelial cells within the cyst wall of a serous or mullerian mucinous tumor of borderline malignancy were initially considered to possibly represent, or were misdiagnosed as. foci of stromal invasion, lymphatic invasion, or both. In the three other cases
an endometrioid adenocarcinoma, a struma ovarii, and a yolk sac tumor
papillary and sheet-like proliferations of mesothelial cells involved the extraovarian pelvic peritoneum: in one of the cases, necrosis of the mesothelial cells was prominent. These foci of extra- ovarian mesothelial hyperplasia were interpreted as metastatic tumor intraoperatively (three cases) and on initial microscopic examination (two cases). Factors that may have predisposed to the mesothelial hyperplasia included large size of the primary tumor (two cases), the presence of metastatic tumor elsewhere in the pelvis (three cases), ascites (two cases), and coexistent endometriosis (two cases). Distinction of mesothelial proliferations from invasive or metastatic ovarian tumor is obviously important in correct classification, staging, and management of the tumor. Awareness of the occasional occurrence of florid mesothelial hyperplasia in patients with ovarian neoplasms and attention to the histologic, histochemical. and immunohistochemical features of the mesothelial proliferation should facilitate the correct diagnosis.
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.
My notes (saved in your browser only)
⚙
Ask this paper
AI returns verbatim quotes from the full text
· source: oa-doi-fallback
ⓘ
Condition tags
endometriosis
MeSH descriptors
Ovarian Neoplasms
Ovary
Adult
Aged
Diagnosis, Differential
Epithelium
Epithelium
Female
Humans
Hyperplasia
Hyperplasia
Middle Aged
Neoplasm Staging
Ovarian Neoplasms
Ovary
Citation neighborhood
(no data yet)
We don't have any in-corpus citations linked to this paper yet.
The paper's references may be in our DB but unresolved to
``paper_id`` (resolution happens at ingest when the cited DOI
matches a row we already have). Run the cross-source citation
reconcile pass to retry.
Source provenance
- europepmc
- last seen: 2026-09-21T06:08:07.822426+00:00
- pubmed
- last seen: 2026-05-13T22:11:44.647872+00:00
- unpaywall
- last seen: 2026-09-23T06:15:37.550144+00:00
License: public-domain-us
· commercial use OK
· attribution required
Courtesy of the U.S. National Library of Medicine